Antimicrobial resistance (AMR) is perhaps the most pressing global health crisis of our time. The pipeline for new antibiotics is slow, meaning that our most powerful tool in the fight against “superbugs” is optimizing the use of the drugs we already possess. The traditional approach to antibiotic dosing—relying on standard, one-size-fits-all nomograms—is increasingly inadequate because […]